MCID: ACT118
MIFTS: 32

Acute Non Lymphoblastic Leukemia

Categories: Rare diseases, Immune diseases, Cancer diseases

Aliases & Classifications for Acute Non Lymphoblastic Leukemia

MalaCards integrated aliases for Acute Non Lymphoblastic Leukemia:

Name: Acute Non Lymphoblastic Leukemia 53
Leukemia, Myelocytic, Acute 73

Classifications:



Summaries for Acute Non Lymphoblastic Leukemia

MalaCards based summary : Acute Non Lymphoblastic Leukemia, also known as leukemia, myelocytic, acute, is related to leukemia, acute myeloid and lymphoblastic leukemia, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Acute Non Lymphoblastic Leukemia is ABCB1 (ATP Binding Cassette Subfamily B Member 1). The drugs Vidarabine and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include myeloid, bone and bone marrow, and related phenotype is hearing/vestibular/ear.

Related Diseases for Acute Non Lymphoblastic Leukemia

Diseases related to Acute Non Lymphoblastic Leukemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 13)
# Related Disease Score Top Affiliating Genes
1 leukemia, acute myeloid 11.2
2 lymphoblastic leukemia 10.7
3 leukemia 10.6
4 myelodysplastic syndrome 10.1
5 porphyria cutanea tarda 9.8
6 polycythemia vera 9.8
7 leukemia, acute lymphoblastic 9.8
8 lymphoma 9.8
9 disseminated intravascular coagulation 9.8
10 porphyria 9.8
11 polycythemia 9.8
12 hematologic cancer 9.2 ABCB1 CSF1
13 ovarian cancer 9.0 ABCB1 CSF1

Graphical network of the top 20 diseases related to Acute Non Lymphoblastic Leukemia:



Diseases related to Acute Non Lymphoblastic Leukemia

Symptoms & Phenotypes for Acute Non Lymphoblastic Leukemia

UMLS symptoms related to Acute Non Lymphoblastic Leukemia:


angina pectoris, chest pain, edema

MGI Mouse Phenotypes related to Acute Non Lymphoblastic Leukemia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hearing/vestibular/ear MP:0005377 8.62 ABCB1 CSF1

Drugs & Therapeutics for Acute Non Lymphoblastic Leukemia

Drugs for Acute Non Lymphoblastic Leukemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 643)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vidarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 24356-66-9 32326 21704
2
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
3
Fludarabine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 21679-14-1, 75607-67-9 30751
4
Etoposide Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 33419-42-0 36462
5
Lenalidomide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 191732-72-6 216326
6
Amsacrine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 51264-14-3 2179
7
Topotecan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 119413-54-6, 123948-87-8 60700
8
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 147-94-4 6253
9
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
10
Thiotepa Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 52-24-4 5453
11
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
12
Idarubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58957-92-9 42890
13
Mitoxantrone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 65271-80-9 4212
14
Daunorubicin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 20830-81-3 30323
15
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1994-09-7, 94-09-7 2337
16
Azacitidine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 320-67-2 9444
17
Decitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2353-33-5 451668
18
Aldesleukin Approved Phase 4,Phase 3,Phase 2,Phase 1 85898-30-2, 110942-02-4
19
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
20
Nicotine Approved Phase 4,Not Applicable 54-11-5 942 89594
21
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
22
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 75614-87-8, 51-45-6 774
23
Bupropion Approved Phase 4,Phase 2 34841-39-9, 34911-55-2 444
24
Posaconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 171228-49-2 147912
25
Micafungin Approved, Investigational Phase 4,Phase 2 235114-32-6 3081921 477468
26 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
27
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 2 1406-16-2
28
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 2 67-97-0 6221 5280795
29
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 2 50-14-6 5280793
30 Molgramostim Investigational Phase 4,Phase 3 99283-10-0
31
Aclarubicin Investigational Phase 4,Phase 2,Phase 1,Not Applicable 57576-44-0 451415
32 Interleukin-2 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
33 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 interferons Phase 4,Phase 2,Phase 1,Not Applicable
35 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
36 topoisomerase I inhibitors Phase 4,Phase 2,Phase 1
37 Adjuvants, Immunologic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Micronutrients Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Gemtuzumab Phase 4,Phase 2,Phase 3,Phase 1
40 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
41 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
42 Cyclosporins Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
44 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
45 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
46 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 Trace Elements Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Angiogenesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
49 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
50 Angiogenesis Modulating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 2490)
# Name Status NCT ID Phase Drugs
1 Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia Unknown status NCT02277847 Phase 4 Idarubicin(8mg/m2) and cytosine arabinoside;Idarubicin(10mg/m2), cytosine arabinoside
2 AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy Unknown status NCT02024308 Phase 4 Fludarabine;Cytarabine
3 Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation Unknown status NCT01806116 Phase 4 decitabine
4 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia Unknown status NCT01587430 Phase 4 high dose ARA-C;standard dose ARA-C
5 Efficacy of G-CSF-Priming in Elderly AML Patients Unknown status NCT00199147 Phase 4 Cytarabine;Etoposide;Idarubicin;G-CSF;Fludarabine
6 Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia Unknown status NCT01997372 Phase 4 ATG
7 Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells(Umbilical Cord Derived) Unknown status NCT02218437 Phase 4 MSC+ATG
8 LAM07: Study to Analyze the Efficacy of a Risk Adapted Treatment Strategy, Including Gemtuzumab Ozogamicin (GO) During Consolidation, for Patients With Acute Myeloid Leukemia (AML) Completed NCT01041040 Phase 4 gemtuzumab
9 Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years Completed NCT00464217 Phase 4 ARA-C;Idarubicin;Leucomax
10 Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Completed NCT00488709 Phase 4 Topotecan;Fludarabine;Cytarabine
11 Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia Completed NCT01819792 Phase 4
12 SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia Completed NCT00487448 Phase 4 Fludarabine;Cytarabine;G-CSF;Idarubicin
13 AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years Completed NCT00180102 Phase 4 Cytarabine vs. Cytarabine+Amsacrine+Mitoxantrone
14 Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia Completed NCT01347996 Phase 4 histamine dihydrochloride and IL-2
15 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome Completed NCT01200355 Phase 4 micafungin;posaconazole
16 AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients Completed NCT00180115 Phase 4 Cytarabine Dosage
17 Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC Completed NCT00180167 Phase 4 randomization between two established Chemotherapies
18 Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia Completed NCT00304447 Phase 4 Mylotarg
19 Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) Completed NCT00686543 Phase 4 Posaconazole
20 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
21 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking Completed NCT00666978 Phase 4 bupropion hydrochloride
22 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking Completed NCT00365508 Phase 4 nicotine lozenge;nicotine patch
23 Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients Recruiting NCT03150134 Phase 4 Cyclosporine;routine reduction of immunosuppressive drugs(cyclosporine)
24 Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML Recruiting NCT02926586 Phase 4 Fludarabine;Cytarabine
25 Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT Recruiting NCT02027064 Phase 4 Interferon-alpha
26 Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients Recruiting NCT02267993 Phase 4 recombinant human thrombopoietin
27 Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections Recruiting NCT02805946 Phase 4 posaconazole
28 Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia Recruiting NCT02618109 Phase 4
29 Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21) Active, not recruiting NCT03026842 Phase 4 Decitabine;Daunorubicin, Cytarabine;Mitoxantrone, Cytarabine;Aclacinomycin, Cytarabine
30 A Rollover Study to Provide Continued Treatment With Eltrombopag Active, not recruiting NCT01957176 Phase 4 ELT
31 King's Invasive Aspergillosis Study II Not yet recruiting NCT02875743 Phase 4 Posaconazole
32 G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor Not yet recruiting NCT02933333 Phase 4
33 A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Not yet recruiting NCT03176849 Phase 4
34 LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML) Terminated NCT01198054 Phase 4 Lenalidomide
35 the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient Unknown status NCT01766375 Phase 3 Cyclosporin A,mycophenolate mofetil,Methotrexate
36 HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia Unknown status NCT01484171 Phase 3 idarubicin
37 A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Unknown status NCT01303796 Phase 3 Sapacitabine and decitabine;Decitabine
38 Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia Unknown status NCT02244658 Phase 3 rhTPO
39 Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia Unknown status NCT02171117 Phase 3
40 Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients Unknown status NCT01633099 Phase 3 Decitabine
41 Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML) Unknown status NCT01145846 Phase 3 Cytarabine plus Daunorubicin [Arm II (AD regimen)]
42 Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T Unknown status NCT00209833 Phase 2, Phase 3 Cytarabine;Idarubicin;Etoposide;Fludarabine;G-CSF;Daunorubicine
43 Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia Unknown status NCT00224614 Phase 3
44 Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study Unknown status NCT00715637 Phase 3 Daunorubicin and Cytarabine;Amonafide and Cytarabine
45 Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia Unknown status NCT00002658 Phase 3 amsacrine;cyclophosphamide;cytarabine;daunorubicin hydrochloride;etoposide;idarubicin;mitoxantrone hydrochloride;thioguanine;tretinoin
46 Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia Unknown status NCT00003602 Phase 3 cytarabine;etoposide;idarubicin;mitoxantrone hydrochloride
47 Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents Unknown status NCT00111345 Phase 2, Phase 3 Anthracyclines;liposomal daunorubicin;2-CDA;AI
48 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia Unknown status NCT00006045 Phase 3 cytarabine;etoposide;mitoxantrone hydrochloride
49 Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia Unknown status NCT02072811 Phase 3 DAC;CLAG;Consolidation, I HAM cycle;II Consolidation HiDAraC;Consolidation, III HiDAraC cycle
50 Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia Unknown status NCT00002549 Phase 3 busulfan;cyclophosphamide;cytarabine;daunorubicin hydrochloride;etoposide;idarubicin;mesna;mitoxantrone hydrochloride

Search NIH Clinical Center for Acute Non Lymphoblastic Leukemia

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Genetic Tests for Acute Non Lymphoblastic Leukemia

Anatomical Context for Acute Non Lymphoblastic Leukemia

MalaCards organs/tissues related to Acute Non Lymphoblastic Leukemia:

41
Myeloid, Bone, Bone Marrow, T Cells, Nk Cells, Kidney, Testes

Publications for Acute Non Lymphoblastic Leukemia

Articles related to Acute Non Lymphoblastic Leukemia:

(show top 50) (show all 66)
# Title Authors Year
1
Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study. ( 20680968 )
2010
2
Spleen and lung involvement by Acinetobacter calcoaceticus bacteremia mimicking deep fungal infection in a child with acute non-lymphoblastic leukemia. ( 16078222 )
2006
3
Consecutive IL-2 and IFN-a2a Maintenance in a Patient with Acute Non-lymphoblastic Leukemia and Renal Cell Cancer. ( 27264260 )
2001
4
Acute non-lymphoblastic leukemia with an unusual chromosomal abnormality in a patient with advanced AIDS. ( 9792401 )
1998
5
Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia. ( 10414235 )
1998
6
Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. ( 9436918 )
1998
7
Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia. ( 9594276 )
1997
8
Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation. ( 9105641 )
1997
9
[Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts]. ( 8960658 )
1996
10
Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia. ( 8996985 )
1996
11
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia. ( 7475276 )
1995
12
12q13, a new recurrent breakpoint in acute non-lymphoblastic leukemia. ( 7697629 )
1995
13
Fluorescent in situ hybridization for assessing the proportion of cells with trisomy 4 in a patient with acute non-lymphoblastic leukemia. ( 7668816 )
1995
14
Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. ( 7630191 )
1995
15
Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia. ( 8182921 )
1994
16
Infection in myelodysplastic syndromes before evolution into acute non-lymphoblastic leukemia. ( 7948962 )
1994
17
Thymidylate synthase in childhood acute non-lymphoblastic leukemia. ( 8067695 )
1994
18
A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission. ( 8035619 )
1994
19
[The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia]. ( 7903627 )
1993
20
Bone marrow transplantation for acute non-lymphoblastic leukemia. ( 1472935 )
1992
21
Mitoxantrone, cytosine-arabinoside and 6-thioguanine (MAT) in the treatment of newly diagnosed acute non-lymphoblastic leukemia in adults. ( 1450441 )
1992
22
Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma. ( 1727215 )
1992
23
Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis. ( 1363283 )
1992
24
Porphyria cutanea tarda associated with acute non-lymphoblastic leukemia. ( 1609784 )
1992
25
N-ras gene mutations in childhood acute non-lymphoblastic leukemia. ( 1921453 )
1991
26
Oral idarubicin plus cytosine arabinoside in the treatment of acute non lymphoblastic leukemia in elderly patients. ( 1820991 )
1991
27
Acute non lymphoblastic leukemia in the Department of Child Health School of Medicine, University of North Sumatera/Dr. Pirngadi Hospital Medan (1983-1988), a preliminary study. ( 1780166 )
1991
28
Monitoring the unmaintained remission of acute non-lymphoblastic leukemia by serial bone marrow cultures. ( 1861533 )
1991
29
Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients). ( 2099400 )
1990
30
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission. ( 2097012 )
1990
31
Allogenic versus autologous marrow transplantation for patients with acute non lymphoblastic leukemia in first complete remission. ( 2358214 )
1990
32
Acute non-lymphoblastic leukemia in children: prognostic factors and results of chemotherapy. ( 2361737 )
1990
33
Karyotypic changes identified by HaeIII restriction endonuclease banding in a patient with M2 acute non-lymphoblastic leukemia. ( 2278962 )
1990
34
Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients. ( 2202469 )
1990
35
Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. ( 2211256 )
1990
36
Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse. ( 2653513 )
1989
37
Colony formation of CFU-MK and other hemopoietic progenitors in patients with acute non-lymphoblastic leukemia at diagnosis and following complete remission. ( 2616265 )
1989
38
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. ( 2653485 )
1989
39
Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results. ( 2654791 )
1989
40
Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia. ( 2912519 )
1989
41
A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells. ( 2585033 )
1989
42
Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndrome. ( 3181878 )
1988
43
Spontaneous complete remission in acute non-lymphoblastic leukemia. ( 3224987 )
1988
44
Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission. ( 3048474 )
1988
45
Long-term survival of children with acute non-lymphoblastic leukemia. ( 3419391 )
1988
46
Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. ( 2894085 )
1988
47
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. ( 3332174 )
1987
48
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. ( 3121464 )
1987
49
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia. ( 3478198 )
1987
50
Residual leukemia cannot be detected in very early remission peripheral blood stem cell collections in acute non-lymphoblastic leukemia. ( 3561018 )
1987

Variations for Acute Non Lymphoblastic Leukemia

Expression for Acute Non Lymphoblastic Leukemia

Search GEO for disease gene expression data for Acute Non Lymphoblastic Leukemia.

Pathways for Acute Non Lymphoblastic Leukemia

GO Terms for Acute Non Lymphoblastic Leukemia

Sources for Acute Non Lymphoblastic Leukemia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....